StockData
Xencor Inc logo

Xencor Inc (XNCR) stock

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)

Close on Nov 18, 2026Market cap $2.56BP/E –Yield –

Xencor cash

Cash and short-term investments held at the end of each period.

Xencor's cash was $44.66M at Jun 30, 2026. For fiscal 2025 it was $54.07M, up 31.0% from the year before. Over ten years it grew -5.6% a year on average. The highest annual figure on record is $529.78M in fiscal 2019.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$54.07M+31.0%
FY2024Dec 31, 2024$41.26M-23.8%
FY2023Dec 31, 2023$54.17M+0.4%
FY2022Dec 31, 2022$53.94M-62.4%
FY2021Dec 31, 2021$143.48M-12.3%
FY2020Dec 31, 2020$163.54M-69.1%
FY2019Dec 31, 2019$529.78M+80.0%
FY2018Dec 31, 2018$294.36M+31.3%
FY2017Dec 31, 2017$224.13M+72.2%
FY2016Dec 31, 2016$130.14M+35.0%
FY2015Dec 31, 2015$96.43M+76.5%
FY2014Dec 31, 2014$54.65M-29.9%
FY2013Dec 31, 2013$77.98M+3272.6%
FY2012Dec 31, 2012$2.31M-84.1%
FY2011Dec 31, 2011$14.54M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$44.66M-0.1%
Q1 FY2026Mar 31, 2026$14.17M-64.5%
Q4 FY2025Dec 31, 2025$54.07M+31.0%
Q3 FY2025Sep 30, 2025$28.29M-3.8%
Q2 FY2025Jun 30, 2025$44.73M+43.6%
Q1 FY2025Mar 31, 2025$39.96M+27.2%
Q4 FY2024Dec 31, 2024$41.26M-23.8%
Q3 FY2024Sep 30, 2024$29.42M-44.2%
Q2 FY2024Jun 30, 2024$31.15M-10.3%
Q1 FY2024Mar 31, 2024$31.42M-56.6%
Q4 FY2023Dec 31, 2023$54.17M+0.4%
Q3 FY2023Sep 30, 2023$52.73M+0.2%
Q2 FY2023Jun 30, 2023$34.71M-29.8%
Q1 FY2023Mar 31, 2023$72.39M-7.5%
Q4 FY2022Dec 31, 2022$53.94M-62.4%
Q3 FY2022Sep 30, 2022$52.65M+27.8%
Q2 FY2022Jun 30, 2022$49.41M-57.3%
Q1 FY2022Mar 31, 2022$78.27M-55.8%
Q4 FY2021Dec 31, 2021$143.48M-12.3%
Q3 FY2021Sep 30, 2021$41.20M-92.5%
Q2 FY2021Jun 30, 2021$115.84M-80.2%
Q1 FY2021Mar 31, 2021$176.97M-69.0%
Q4 FY2020Dec 31, 2020$163.54M-69.1%
Q3 FY2020Sep 30, 2020$545.78M-0.1%
Q2 FY2020Jun 30, 2020$583.65M+15.5%
Q1 FY2020Mar 31, 2020$571.65M+68.0%
Q4 FY2019Dec 31, 2019$529.78M+80.0%
Q3 FY2019Sep 30, 2019$546.48M+101.2%
Q2 FY2019Jun 30, 2019$505.17M+97.8%
Q1 FY2019Mar 31, 2019$340.36M-26.4%
Q4 FY2018Dec 31, 2018$294.36M+31.3%
Q3 FY2018Sep 30, 2018$271.60M+29.4%
Q2 FY2018Jun 30, 2018$255.41M+35.5%
Q1 FY2018Mar 31, 2018$462.41M+198.7%
Q4 FY2017Dec 31, 2017$224.13M+72.2%
Q3 FY2017Sep 30, 2017$209.95M+101.3%
Q2 FY2017Jun 30, 2017$188.49M–
Q1 FY2017Mar 31, 2017$154.79M–
Q4 FY2016Dec 31, 2016$130.14M–
Q3 FY2016Sep 30, 2016$104.31M–

More Xencor figures

See a number that looks wrong?